﻿<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://owl.unipharm.com/mediawiki/index.php?action=history&amp;feed=atom&amp;title=Customer_Service%3APharmacist_Letter-Subscription</id>
	<title>Customer Service:Pharmacist Letter-Subscription - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://owl.unipharm.com/mediawiki/index.php?action=history&amp;feed=atom&amp;title=Customer_Service%3APharmacist_Letter-Subscription"/>
	<link rel="alternate" type="text/html" href="https://owl.unipharm.com/mediawiki/index.php?title=Customer_Service:Pharmacist_Letter-Subscription&amp;action=history"/>
	<updated>2026-09-01T12:48:40Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.35.4</generator>
	<entry>
		<id>https://owl.unipharm.com/mediawiki/index.php?title=Customer_Service:Pharmacist_Letter-Subscription&amp;diff=9968&amp;oldid=prev</id>
		<title>Nancyn at 00:07, 21 November 2017</title>
		<link rel="alternate" type="text/html" href="https://owl.unipharm.com/mediawiki/index.php?title=Customer_Service:Pharmacist_Letter-Subscription&amp;diff=9968&amp;oldid=prev"/>
		<updated>2017-11-21T00:07:42Z</updated>

		<summary type="html">&lt;p&gt;&lt;/p&gt;
&lt;table class=&quot;diff diff-contentalign-left diff-editfont-monospace&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;en&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;← Older revision&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;Revision as of 00:07, 21 November 2017&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;
  &lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 1:&lt;/td&gt;
  &lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 1:&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
  &lt;td class=&quot;diff-marker&quot;&gt;&amp;#160;&lt;/td&gt;
  &lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;==Overview==&lt;/div&gt;&lt;/td&gt;
  &lt;td class=&quot;diff-marker&quot;&gt;&amp;#160;&lt;/td&gt;
  &lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;==Overview==&lt;/div&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
  &lt;td class=&quot;diff-marker&quot;&gt;&amp;#160;&lt;/td&gt;
  &lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;It has been decided that as of January 2018, uniPHARM will not continue to offer the Pharmacist Letter free of charge. There was a lack of support in the last survey sent out regarding the Letter from shareholders. As the annual cost was $20,000 US for the subscription, it was felt that this money could be better used to bring more value to you all by underwriting the cost of BCPhA and CFIB membership fees. The board of directors felt this was a better use of everyone's money.&lt;/div&gt;&lt;/td&gt;
  &lt;td class=&quot;diff-marker&quot;&gt;&amp;#160;&lt;/td&gt;
  &lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;It has been decided that as of January 2018, uniPHARM will not continue to offer the Pharmacist Letter free of charge. There was a lack of support in the last survey sent out regarding the Letter from shareholders. As the annual cost was $20,000 US for the subscription, it was felt that this money could be better used to bring more value to you all by underwriting the cost of BCPhA and CFIB membership fees. The board of directors felt this was a better use of everyone's money.&lt;/div&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
  &lt;td colspan=&quot;2&quot; class=&quot;diff-empty&quot;&gt;&amp;#160;&lt;/td&gt;
  &lt;td class=&quot;diff-marker&quot;&gt;+&lt;/td&gt;
  &lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
  &lt;td colspan=&quot;2&quot; class=&quot;diff-empty&quot;&gt;&amp;#160;&lt;/td&gt;
  &lt;td class=&quot;diff-marker&quot;&gt;+&lt;/td&gt;
  &lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;With so much continuing education now available free of charge, this change should not impact the shareholder's ability to reach their annual requirements for the College, if they had been using their CEs. &lt;/div&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
  &lt;td class=&quot;diff-marker&quot;&gt;&amp;#160;&lt;/td&gt;
  &lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;/td&gt;
  &lt;td class=&quot;diff-marker&quot;&gt;&amp;#160;&lt;/td&gt;
  &lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
  &lt;td class=&quot;diff-marker&quot;&gt;&amp;#160;&lt;/td&gt;
  &lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;==Website for Subscription==&lt;/div&gt;&lt;/td&gt;
  &lt;td class=&quot;diff-marker&quot;&gt;&amp;#160;&lt;/td&gt;
  &lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;==Website for Subscription==&lt;/div&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
  &lt;td class=&quot;diff-marker&quot;&gt;−&lt;/td&gt;
  &lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;del class=&quot;diffchange diffchange-inline&quot;&gt;You&lt;/del&gt; can still renew &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;your&lt;/del&gt; &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;own subscription&lt;/del&gt; if &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;you&lt;/del&gt; would like by going to the Pharmacist Letter website at  [https://ca-pharmacist.therapeuticresearch.com/Home/PLC https://ca-pharmacist.therapeuticresearch.com/Home/PLC] and subscribing on &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;your&lt;/del&gt; own.&lt;/div&gt;&lt;/td&gt;
  &lt;td class=&quot;diff-marker&quot;&gt;+&lt;/td&gt;
  &lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;Shareholders&lt;/ins&gt; can still renew &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;their&lt;/ins&gt; &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;subscriptions&lt;/ins&gt; if &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;they&lt;/ins&gt; would like by going to the Pharmacist Letter website at  [https://ca-pharmacist.therapeuticresearch.com/Home/PLC https://ca-pharmacist.therapeuticresearch.com/Home/PLC] and subscribing on &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;their&lt;/ins&gt; own.&lt;/div&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
  &lt;td class=&quot;diff-marker&quot;&gt;&amp;#160;&lt;/td&gt;
  &lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;/td&gt;
  &lt;td class=&quot;diff-marker&quot;&gt;&amp;#160;&lt;/td&gt;
  &lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
  &lt;td class=&quot;diff-marker&quot;&gt;&amp;#160;&lt;/td&gt;
  &lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;==Contacts==&lt;/div&gt;&lt;/td&gt;
  &lt;td class=&quot;diff-marker&quot;&gt;&amp;#160;&lt;/td&gt;
  &lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;==Contacts==&lt;/div&gt;&lt;/td&gt;
&lt;/tr&gt;

&lt;!-- diff cache key wikidb:diff:wikidiff2:1.12:old-9966:rev-9968:1.11.0 --&gt;
&lt;/table&gt;</summary>
		<author><name>Nancyn</name></author>
	</entry>
	<entry>
		<id>https://owl.unipharm.com/mediawiki/index.php?title=Customer_Service:Pharmacist_Letter-Subscription&amp;diff=9966&amp;oldid=prev</id>
		<title>Nancyn: Created page with &quot;==Overview== It has been decided that as of January 2018, uniPHARM will not continue to offer the Pharmacist Letter free of charge. There was a lack of support in the last sur...&quot;</title>
		<link rel="alternate" type="text/html" href="https://owl.unipharm.com/mediawiki/index.php?title=Customer_Service:Pharmacist_Letter-Subscription&amp;diff=9966&amp;oldid=prev"/>
		<updated>2017-11-21T00:05:02Z</updated>

		<summary type="html">&lt;p&gt;Created page with &amp;quot;==Overview== It has been decided that as of January 2018, uniPHARM will not continue to offer the Pharmacist Letter free of charge. There was a lack of support in the last sur...&amp;quot;&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;==Overview==&lt;br /&gt;
It has been decided that as of January 2018, uniPHARM will not continue to offer the Pharmacist Letter free of charge. There was a lack of support in the last survey sent out regarding the Letter from shareholders. As the annual cost was $20,000 US for the subscription, it was felt that this money could be better used to bring more value to you all by underwriting the cost of BCPhA and CFIB membership fees. The board of directors felt this was a better use of everyone's money.&lt;br /&gt;
&lt;br /&gt;
==Website for Subscription==&lt;br /&gt;
You can still renew your own subscription if you would like by going to the Pharmacist Letter website at  [https://ca-pharmacist.therapeuticresearch.com/Home/PLC https://ca-pharmacist.therapeuticresearch.com/Home/PLC] and subscribing on your own.&lt;br /&gt;
&lt;br /&gt;
==Contacts==&lt;br /&gt;
*'''Aaron Morse'''&lt;br /&gt;
&lt;br /&gt;
Therapeutic Research Center&lt;br /&gt;
&lt;br /&gt;
''Home of: Pharmacist’s Letter | Prescriber’s Letter | Pharmacy Technician’s Letter | Pharmacy Technician’s University | Natural Medicines Comprehensive Database | Natural Standard | Ident-A-Drug Reference''&lt;br /&gt;
&lt;br /&gt;
1 David Square&lt;br /&gt;
&lt;br /&gt;
Somerville MA 02144&lt;br /&gt;
&lt;br /&gt;
TEL (617) 591-3334&lt;br /&gt;
&lt;br /&gt;
EMAIL AMorse@Pletter.com [mailto:AMorse@Pletter.com]&lt;br /&gt;
&lt;br /&gt;
[[Category:Pharmacist Letters]]&lt;/div&gt;</summary>
		<author><name>Nancyn</name></author>
	</entry>
</feed>